SOFT
Phase 3 Completed
3,066 enrolled 15 charts
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Phase 2 Completed
180 enrolled 14 charts
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
Phase 3 Completed
1,803 enrolled 20 charts
LAPATAM
Phase 1 Completed
20 enrolled
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
Phase 3 Completed
1,099 enrolled
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Phase 2 Completed
124 enrolled 14 charts
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
Phase 3 Completed
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Phase 3 Completed
636 enrolled
Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Phase 2 Completed
77 enrolled
Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients
Phase 3 Completed
2,021 enrolled
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
Phase 3 Completed
667 enrolled
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
Phase 3 Completed
224 enrolled
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Phase 2 Completed
70 enrolled 11 charts
Co-SOFT
Phase 3 Completed
86 enrolled 4 charts
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Phase 3 Completed
19,747 enrolled
10-93
Phase 3 Completed
473 enrolled
12-93
Phase 3 Completed
452 enrolled
15-95
Phase 3 Completed
344 enrolled
SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer
Phase 3 Completed
1,558 enrolled
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
Phase 3 Completed
313 enrolled
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Phase 3 Completed
342 enrolled
Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
Phase 3 Completed
2,411 enrolled